Creatinine Muscle Index in UK Biobank: Comparison with MRI and associations with Frailty and Mortality

Clicks: 39
ID: 313836
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #5 of 153 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Skeletal muscle wasting due to aging, acute illness and chronic disease is associated with adverse outcomes including mortality, frailty and multi-morbidity. We investigated the relationship of creatinine muscle index (CMI), a serum biological signature of muscle mass, in UK Biobank participants with gold standard muscle measurement and adverse outcomes. Method We compared CMI with Magnetic Resonance Imaging (MRI) measured muscle mass in 33 799 participants using linear regression. We then assessed CMI’s ability to discriminate low muscle mass (≤2.5 SD below the mean). In the full UK Biobank cohort (n = 450 812), we utilised Cox-proportional hazards models to investigate associations between CMI with mortality, frailty and comorbidity. Results CMI demonstrated moderate to good linear correlation with gold-standard MRI muscle mass measurements (R males: 0.68 [0.60–0.76]; females: 0.65 [0.56–0.73]), after accounting for data imbalance. CMI discriminated muscle mass ≤ 2.5 standard deviations from the mean, with an area under the curve of 0.80 (95% CI:0.75–0.86) in males and 0.84 (95% CI:0.78–0.89) in females. CMI consistently decreased with increasing age, frailty and comorbidity. Over an 8-year follow-up, lower CMI was associated with higher morality: adjusted hazard ratio for the 25th vs 75th CMI centiles were 0.61(95% CI: 0.58–0.66) in males and 0.72 (95% CI: 0.66–0.78) in females. Conclusions In over 450 000 UK Biobank participants, low CMI was significantly associated with baseline comorbidity, frailty and survival on follow-up (independent of age, sex and comorbidity). This study supports CMI as a potential biological signature for skeletal muscle wasting in clinical and research settings.
Reference Key
openalex_W7160706029 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Giada Azzopardi, Thomas Davies, Myles J Lewis, Zudin Puthucheary, John R Prowle
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag139
URL
https://doi.org/10.1093/ckj/sfag139
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.